Lundqvist Lab

The Lundqvist Lab studies how NK cells are regulated in the microenvironment of solid tumors

[Lundqvist Lab @LundqvistLab]

Meeting new and old friends at #CITIM2023 @EgleKvedaraite

[Lundqvist Lab @LundqvistLab]

Congratulation to Kristina Witt for successfully defending her thesis. @KWitt28583090 @SamirNKhleif #karolinska

[Francesco Colucci @DrFran_Colucci]

Seven steps towards health and happiness in the lab https://t.co/IeJBlwvBBe

[Lundqvist Lab @LundqvistLab]

Dr. Dhifaf Sarhan (ex #LundqvistLab) presenting her work on targeting scavenger receptors to augment cancer immune therapy against pancreatic cancer at the #SITC2018.

[Lundqvist Lab @LundqvistLab]

@thoren_lab @SilviaPesce5 @SahlgrenskaAcad @uniofgothenburg Doc GW did most, if not all of the work!

[Immunometabolism Network @ImmunoMet]

In case you missed this: FACS causes oxidative stress and alters the metabolic status of cells. Thus, metabolomic results from sorted cells do not accurately reflect physiological conditions prior to sorting. https://t.co/MrTqUIqgdj

[Lundqvist Lab @LundqvistLab]

Congratulations Kristina Witt on publishing your paper on Cripto-1
vaccination against breast cancer! #Cripto1 #Karolinska #LundqvistLab https://t.co/jkL76wIAdR

[Rizwan Romee @romeerizwan]

Our IL15 superagonist paper made it to the cover page of Blood!! The figure shows predominantly gamma delta T cell infiltration in the skin in these pts.

[Thorén lab @thoren_lab]

T and NK cell killing of cancer cells - key role role for TNF. https://t.co/iXGIdSlcxZ

[AACR @AACR]

#ICYMI: On May 4, the U.S. Food and Drug Administration (FDA) approved a combination of molecularly targeted therapeutics for the treatment of a certain type of thyroid cancer. https://t.co/VGrUYUOzrs

[Wafik S. El-Deiry, MD, PhD, FACP @weldeiry]

JCI - Dose intensification of TRAIL-inducing ONC201 inhibits metastasis and promotes intratumoral NK cell recruitment https://t.co/N1uoTlM6E9

[Jason Luke, MD, FACP, FASCO @jasonlukemd]

After #immunotherapy tox are pts precluded from IO? @IC_ONC_Chicago #IC_ONC #IC_ONC_Chicago Answer: re-treatment may be possible but must consider all options & have informed consent. Retro series suggest 1/3 chance irAE tox flare tho manageable w steroids https://t.co/f3pYRQv15u

[Parker Institute for Cancer Immunotherapy @parkerici]

CAR-T therapy is now approved by the FDA for large B-cell #lymphoma! It had been approved for B-cell ALL in young patients last August. The treatment was developed by PICI director Carl June. #leukemia #leusm #immunotherapy https://t.co/YPpJ6QSAi5

[Parker Institute for Cancer Immunotherapy @parkerici]

How can the herpes virus help #immunotherapy fight #skincancer? First in human study shows oncolytic virus + pembro has response rate of 62% in metastatic #melanoma led by PICI’s Antoni Ribas @UCLAJCCC @CellCellPress #NCRM18 #melanomaawareness

https://t.co/HpijDgBjIF

[AACR @AACR]

On the blog: AACR Annual Meeting 2018: Novel Immunotherapy Combinations to Combat Resistance to Checkpoint Inhibition. https://t.co/uGhJNhBa1l